Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Advanced Healthcare Materials is an international, interdisciplinary forum for peer-reviewed papers on materials science aimed at promoting human health. Advanced Healthcare Materials was published as ...

Ready for a master's that makes a difference? Miami University's Advanced Inquiry Program (AIP) is an innovative online degree, integrating flexible courses with unparalleled experiential learning at ...

While earlier stages of ovarian cancer are easier to treat than advanced stages, early stages cause very few noticeable symptoms. This isn’t the case for advanced, or late-stage, ovarian cancer.

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.

Isomorphic Labs has raised $600m in its first external funding round as it pushes forward with artificial intelligence (AI)-driven drug discovery. Thrive Capital led the financing round, with ...

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

Jan 20 : Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday. The ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.